Sarah Batson

Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine

Sarah Batson, Cesira de Chiara, Vita Majce et al. · Nature Communications · 2017 · 95 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +15

Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups

Gregory Y.H. Lip, Stephen Mitchell, Xianchen Liu et al. · International Journal of Cardiology · 2015 · 87 citations

Medicine, Cardiology, Pharmacotherapy +10

Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis

Sarah Batson, Stephen Mitchell, Ricarda Windisch et al. · OncoTargets and Therapy · 2017 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Treatments for chronic myeloid leukemia: a qualitative systematic review

Stephen Mitchell, Ferdinand, Tumur et al. · Journal of Blood Medicine · 2012 · 46 citations · Full text

Medicine, Hematology, Pharmacology +13

Design and synthesis of new hydroxyethylamines as inhibitors of d-alanyl-d-lactate ligase (VanA) and d-alanyl-d-alanine ligase (DdlB)

Matej Sova, Gašper Čadež, Vita Majce et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9